For this reason, Rossowska et al. [145] reported that temporary elimination of IL-10 represents an effective way to decrease the immune suppression mediated by MDSCs and considered a useful approach to enhance the efficacy of immunotherapy for cancer. The gene discussed is IL10; the disease is cancer.